0001415889-23-008651.txt : 20230523
0001415889-23-008651.hdr.sgml : 20230523
20230523175346
ACCESSION NUMBER: 0001415889-23-008651
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230522
FILED AS OF DATE: 20230523
DATE AS OF CHANGE: 20230523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HANISH ARNOLD C
CENTRAL INDEX KEY: 0001233253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34475
FILM NUMBER: 23950034
MAIL ADDRESS:
STREET 1: 201 ELLIOTT AVENUE WEST
CITY: SEATTLE
STATE: WA
ZIP: 98119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OMEROS CORP
CENTRAL INDEX KEY: 0001285819
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911663741
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 ELLIOTT AVENUE WEST
CITY: SEATTLE
STATE: WA
ZIP: 98119
BUSINESS PHONE: 206-676-5000
MAIL ADDRESS:
STREET 1: 201 ELLIOTT AVENUE WEST
CITY: SEATTLE
STATE: WA
ZIP: 98119
4
1
form4-05232023_090541.xml
X0407
4
2023-05-22
0001285819
OMEROS CORP
OMER
0001233253
HANISH ARNOLD C
C/O OMEROS CORPORATION
201 ELLIOTT AVENUE WEST
SEATTLE
WA
98119
true
false
false
false
0
Common Stock
2023-05-22
4
M
0
5000
5.30
A
5000
D
Common Stock
2023-05-22
4
S
0
5000
6.46
D
0
D
Common Stock
12400
I
Arnold C. Hanish Living Trust
Stock Option (Right to Buy)
5.30
2023-05-22
4
M
0
5000
0
D
2014-05-22
2023-05-23
Common Stock
5000
0
D
This transaction was executed in multiple trades at prices ranging from $6.34 to $6.61. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
These shares have not been sold and are held of record by the Arnold C. Hanish Living Trust, for which the reporting person serves as sole trustee.
The reported transaction reflects the exercise of expiring stock options and the simultaneous sale of the shares underlying the exercised option.
/s/ Peter B. Cancelmo, Attorney-in-Fact
2023-05-23